Skip to content

KINNEVIK AB (PUBL)

Follow

13F filer, CIK 1766574, STOCKHOLM, Sweden

KINNEVIK AB (PUBL) reported $89,292,510 across 1 holding for the quarter ended 2024-06-30, in a 13F-HR filed 2024-07-08.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-078298

Period
2024-06-30
Reported value
$89.3M
Holdings
1
Top 10 weight
100%
New
0
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RXRXadded+1,500,000$11.2M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q2 2024

Share positions as resolved from 13F-HR 0001104659-24-078298, largest first. % of portfolio is the value over $89,292,510, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q3: restricted; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 10,405,668 shares; 2024Q1: 10,405,668 shares; 2024Q2: 11,905,668 shares 11,905,668$89.3M100%+1,500,000Timeline

How Q2 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-078298 base2024-07-08acceptance time not in the bulk data set